Advice
following an abbreviated submission:
ciprofloxacin+dexamethasone (Cilodex®) is accepted for restricted use within NHS Scotland.
Indication under review: for treatment of the following infections in adults and children:
Acute otitis media in patients with tympanostomy tubes (AOMT)
Acute otitis externa
SMC restriction: Treatment of acute otitis media in patients with tympanostomy tubes (AOMT).
Cilodex® provides a licensed alternative to “off-label” use of ciprofloxacin and dexamethasone eye drops in the treatment of AOMT and is available at an equivalent cost.
Download detailed advice126KB (PDF)
Medicine details
- Medicine name:
- ciprofloxacin 3mg/mL + dexamethasone 1mg/mL ear drops (Cilodex)
- SMC ID:
- 1256/17
- Indication:
- for treatment of the following infections in adults and children: Acute otitis media in patients with tympanostomy tubes (AOMT), Acute otitis externa
- Pharmaceutical company
- Novartis Pharmaceuticals UK Ltd
- BNF chapter
- Infections
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 10 July 2017